BDS
LCTX icon

Banco de Sabadell’s Lineage Cell Therapeutics LCTX Stock Holding History

Banco de Sabadell’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-20,000
Closed -$18K – 368
2020
Q2 		$18K Hold
20,000
– – ﹤0.01% 286
2020
Q1 		$16K Hold
20,000
– – ﹤0.01% 299
2019
Q4 		$17K Hold
20,000
– – ﹤0.01% 313
2019
Q3 		$20K Hold
20,000
– – ﹤0.01% 320
2019
Q2 		$22K Buy
+20,000
New +$23K ﹤0.01% 342
2019
Q1 		– Sell
-20,000
Closed -$19K – 392
2018
Q4 		$19K Sell
20,000
-2,860
-13% -$4.38K ﹤0.01% 383
2018
Q3 		$47K Hold
22,860
– – 0.01% 384
2018
Q2 		$41K Hold
22,860
– – 0.01% 390
2018
Q1 		$49K Hold
22,860
– – 0.01% 384
2017
Q4 		$43K Buy
+22,860
New +$49.9K 0.01% 272

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return